Delivery Order SPE2DB20D3101-SPE2DB26FQTL8
Award Date 11/7/25
Potential Completion Date 11/10/25
Potential Value $1.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $4,863.02 to AmerisourceBergen Drug Corp for Gadavist 10 mmol/10 mL vials. This competitively awarded, firm fixed-price delivery order was issued on August 11, 2025, with an ultimate completion date of August 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Gadavist is a gadolinium-based contrast agent used in magnetic resonance imaging procedures, representing a specialized...
- The Defense Logistics Agency awarded a delivery order valued at $1,704.90 to AmerisourceBergen Drug Corp for Gadavist 1 mmol/ml bulk vials (30 ml) on May 14, 2025, with an ultimate completion date of May 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Gadavist is a gadolinium-based contrast agent used in magnetic resonance imaging procedures...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Gadavist 10 mmol/10 mL vials with a ceiling value of $1,501.90. This non-competitive, firm fixed-price delivery order was awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Gadavist is a contrast agent used in medical imaging procedures, reflecting the company's role as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies on October 27, 2025, with a ceiling value of $2,341.23. The contract covers the supply of Gadavist 7.5 mmol/7.5 ml vials, a gadolinium-based contrast agent used in medical imaging procedures. This is a firm fixed price delivery order with an ultimate completion date of October 28, 2025, and represents performance at the contractor's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $4,657.14 to AmerisourceBergen Drug Corp for Gadavist 10 mmol/10 ml vials on September 23, 2025, with an ultimate completion date of September 24, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement of pharmaceutical inventory to support federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $1,136.62 to AmerisourceBergen Drug Corp for Gadavist 1 mmol/mL bulk vial (30 mL) on June 17, 2025, with completion scheduled for June 18, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical supplier of...
- The Defense Logistics Agency awarded a delivery order valued at $1,501.90 to AmerisourceBergen Drug Corp for Gadavist 10 mmol/10 ml vials on September 22, 2025. This is a firm fixed price delivery order with an ultimate completion date of September 23, 2025, with no set-aside designation. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a $2,686.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Gadavist 15 mmol/15 ml vials, a contrast agent used in medical imaging procedures. The award was issued on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-competitive, non-set-aside delivery order represents a routine procurement of pharmaceutical supplies to support federal medical operations. The work will be performed at AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,952.55 to AmerisourceBergen Drug Corp for the supply of Gadavist 10 mmol/10 ml vials on November 4, 2025, with an ultimate completion date of November 5, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The order will be fulfilled from the vendor's corporate office located in...
- The Defense Logistics Agency awarded a $1,501.90 delivery order to AmerisourceBergen Drug Corp on June 26, 2025, for the supply of Gadavist 10 mmol/10 ml vials. This competitively awarded, firm fixed-price contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, with an...